JAN 06, 2016 6:40 AM PST

Saffron Molecule Prevents Liver Cancer

WRITTEN BY: Xuan Pham
In addition to enhancing the flavors of foods, saffron – the world’s priciest spice – may also prevent liver cancer.
Saffron threads
A team of researchers from the United Arab Emirates (UAE) University announced in a new study that a saffron-based “crocin” biomolecule has the ability to protect against a deadly form of liver cancer, known as hepatocellular carcinoma (HCC).

At a staggering $5,000 to 10,000 per pound, the cost of the saffron spice rivals that of gold. This “red gold,” as saffron is sometimes called, is prized for its unique aromatics that can’t be duplicated in any other form. More than 150 molecules give saffron its unique aroma and color characteristics. Among them, crocin is the main carotenoid compound that’s responsible for saffron’s distinctive reddish hue. Crocin is known to be a powerful antioxidant that’s been linked to many healthy benefits such as relieving symptoms of depression, and premenstrual syndrome.
 

Lead by professor Amr Amin, the team of researchers zeroed in on crocin and asked whether this biomolecule has anti-cancer effects in a rat model of liver cancer. They also analyzed gene expression patterns in mouse tissues of HCC treated and untreated with crocin. Finally, they exposed a liver cancer cell line (HepG2) to various crocin concentrations and assessed cell viability.

The researchers found that crocin prevented the cancer cells from growing and induced more cancer cells to die. In gene expression analysis, they found that crocin inhibited a protein complex NF-kB that’s produced as part of the body’s inflammatory response. Together, the researchers conclude that crocin shows anti-proliferative, pro-apoptotic, and anti-inflammatory properties against HCC.

Of course this result is in the setting of a lab with an induced liver cancer cell line. However, the findings “introduce crocin as a candidate chemopreventative agent against hepatocellular carcinoma,” and identified a potential mechanism for how the crocin molecule in saffron exerts its anti-tumor effects cancer. The study also identified “NF-kB as a potential regulatory hub, and therefore, a candidate therapeutic drug target.”

Sources: Article via Recent Patents on Anti-Cancer Drug Discovery 
 
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 29, 2020
Clinical & Molecular DX
More Frequent Trips to the Pediatrician Linked to a Future Autism Diagnosis
OCT 29, 2020
More Frequent Trips to the Pediatrician Linked to a Future Autism Diagnosis
 
DEC 23, 2020
Clinical & Molecular DX
Smartphone Device Uses CRISPR to Check for COVID
DEC 23, 2020
Smartphone Device Uses CRISPR to Check for COVID
Quick, portable, and ultrasensitive—a new smartphone test for COVID-19 checks all the boxes needed to get a handle ...
JAN 18, 2021
Cancer
An "E-Nose" Could Help Doctors Diagnose Breast Cancer and Its Subtypes
JAN 18, 2021
An "E-Nose" Could Help Doctors Diagnose Breast Cancer and Its Subtypes
Breast cancer is one of the most well-studied cancers in modern medicine. Diagnostics can already differentiate between ...
JAN 26, 2021
Cardiology
Your Nose Could Tell You Something About Your Heart Health
JAN 26, 2021
Your Nose Could Tell You Something About Your Heart Health
As we get older, many things change in our bodies. We lose touch with the newest fashion trends, or which new phone is b ...
JAN 26, 2021
Genetics & Genomics
Why Only Some People With a Rare Mutation Get a Heart Condition
JAN 26, 2021
Why Only Some People With a Rare Mutation Get a Heart Condition
Scientists have found a way to explain why a heart condition called hypertrophic cardiomyopathy (HCM) can be so differen ...
FEB 23, 2021
Genetics & Genomics
New Insight Into Genetic Basis of IBD From African-American Patients
FEB 23, 2021
New Insight Into Genetic Basis of IBD From African-American Patients
The small variations in the genome that lead to differences in biology, including risk for diseases, can't be assumed to ...
Loading Comments...